Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results from an Open-Label Extension Study

D. J. Wallace, K. Hobbs, M. E.B. Clowse, M. Petri, V. Strand, M. Pike, J. T. Merrill, P. Leszczyński, C. M. Neuwelt, S. Jeka, F. Houssiau, M. Keiserman, J. Ordi-Ros, S. Bongardt, B. Kilgallen, C. Galateanu, K. Kalunian, R. Furie, C. Gordon

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results from an Open-Label Extension Study'. Together they form a unique fingerprint.

Medicine & Life Sciences